Egyptian Board Gastroenterology & Hepatology flashcards
Egyptian Board Gastroenterology & Hepatology · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Chicago Classification v4.0
- High-resolution manometry scheme defining esophageal motility disorders by integrated relaxation pressure and distal contractile integral, diagnosing achalasia subtypes and esophagogastric junction outflow obstruction.
- Barrett esophagus definition
- Columnar-lined esophagus with intestinal metaplasia extending at least 1 cm above the gastroesophageal junction, requiring endoscopic surveillance intervals determined by dysplasia grade.
- Los Angeles grade D
- Reflux esophagitis with mucosal breaks involving at least 75% of the esophageal circumference, representing the most severe grade and predicting higher relapse risk.
- H. pylori test-and-treat
- Strategy using urea breath test or stool antigen to detect active infection in dyspeptic patients without alarm features, followed by eradication and confirmation testing.
- Forrest classification
- Endoscopic stigmata of peptic ulcer bleeding: Ia spurting, Ib oozing, IIa visible vessel, IIb adherent clot, IIc flat pigmented spot, III clean base; grades Ia-IIb need hemostasis.
- Correa cascade
- Stepwise gastric carcinogenesis from Helicobacter pylori chronic gastritis through atrophy, intestinal metaplasia, and dysplasia to intestinal-type adenocarcinoma.
- Tissue transglutaminase IgA
- Preferred serologic test for celiac disease; requires concurrent total IgA measurement because IgA deficiency causes false-negative results.
- Marsh-Oberhuber grading
- Histologic classification of celiac enteropathy ranging from intraepithelial lymphocytosis alone to total villous atrophy with crypt hyperplasia.
- SeHCAT test
- Nuclear medicine study measuring bile acid retention; retention below 10% at seven days supports bile acid diarrhea, which responds to bile acid sequestrants.
- Travis criteria
- Day-3 assessment after intravenous steroids in acute severe ulcerative colitis; more than eight stools or C-reactive protein above 45 mg/L predicts need for rescue therapy or colectomy.
- Fecal calprotectin thresholds
- Stool marker of neutrophilic inflammation; values below 50 micrograms per gram suggest mucosal healing, values above 250 suggest active inflammatory bowel disease.
- Primary sclerosing cholangitis association
- Chronic cholestatic disease with multifocal biliary strictures, strongly associated with ulcerative colitis and increased colorectal neoplasia risk requiring surveillance colonoscopy.
- Adenoma surveillance interval
- Follow-up colonoscopy timing based on polyp findings: three years for advanced neoplasia, seven to ten years for one or two small tubular adenomas.
- Lynch syndrome screening
- Universal tumor testing with mismatch repair immunohistochemistry or microsatellite instability, followed by germline testing, identifies hereditary nonpolyposis colorectal cancer.
- Serum-ascites albumin gradient
- Difference between serum and ascitic albumin; a value of 1.1 g/dL or greater indicates portal hypertension as the cause of ascites.
- Spontaneous bacterial peritonitis
- Ascitic fluid polymorphonuclear cell count of 250 per cubic millimeter or more, requiring prompt antibiotics, usually a third-generation cephalosporin plus albumin.
- MELD 3.0
- Liver transplant allocation score incorporating bilirubin, international normalized ratio, creatinine, sodium, albumin, and sex, replacing earlier MELD-Na versions.
- LI-RADS 5
- Multiphasic imaging category diagnostic of hepatocellular carcinoma in cirrhosis, showing arterial phase hyperenhancement with washout or capsule, obviating biopsy.
- Gallstone pancreatitis management
- Urgent endoscopic retrograde cholangiopancreatography for cholangitis or persistent obstruction, with cholecystectomy during the index admission for mild disease.
- Autoimmune pancreatitis type 1
- IgG4-related pancreatic disease with sausage-shaped pancreas and elevated IgG4, responding to corticosteroids; type 2 is linked to inflammatory bowel disease.
- Glasgow-Blatchford score
- Risk score using urea, hemoglobin, blood pressure, heart rate, and presentation features; a score of 1 or less identifies very low-risk upper gastrointestinal bleeding.
- Ischemic colitis distribution
- Segmental mucosal injury at watershed zones such as the splenic flexure and rectosigmoid; the rectum is usually spared because of dual collateral blood supply.
- Post-ERCP pancreatitis prophylaxis
- Rectal indomethacin plus aggressive intravenous hydration, with prophylactic pancreatic stent placement in high-risk patients, reduces pancreatitis after endoscopic retrograde cholangiopancreatography.
- Adenoma detection rate
- Quality metric for screening colonoscopy; target of at least 25 percent overall reflects adequate mucosal inspection and correlates with reduced interval colorectal cancer.
- Refeeding syndrome
- Hypophosphatemia, hypokalemia, and hypomagnesemia after reintroducing nutrition in malnourished patients; start low-calorie feeding and supplement thiamine before feeding.
- Bariatric surgery thresholds
- Body mass index of 35 or more with comorbidity, or 40 or more regardless of comorbidity, qualifies for metabolic and bariatric surgical evaluation.
- Fidaxomicin first-line
- Preferred treatment for initial Clostridioides difficile infection, associated with lower recurrence than vancomycin; vancomycin is an acceptable alternative.
- Amebic liver abscess
- Entamoeba histolytica infection of the liver with positive serology in most patients; treated with metronidazole followed by a luminal agent such as paromomycin.
- Strongyloides hyperinfection
- Disseminated Strongyloides stercoralis infection during corticosteroid therapy, causing gram-negative sepsis; screen and treat at-risk patients before immunosuppression.
- Number needed to treat
- Reciprocal of absolute risk reduction; estimates how many patients must receive an intervention to prevent one additional adverse outcome.
- Likelihood ratio
- Ratio of the probability of a test result in diseased versus nondiseased patients; unlike predictive values, it is independent of disease prevalence.
- Informed consent elements
- Capacity, adequate disclosure, comprehension, and voluntariness; delirium impairs capacity regardless of surrogate or family preference.